Skip to main content
Top
Published in: European Radiology 6/2006

01-06-2006 | Gastrointestinal

Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging

Authors: Arne S. Borthne, Michael Abdelnoor, Trygve Storaas, Claude Pierre-Jerome, Nils-E. Kløw

Published in: European Radiology | Issue 6/2006

Login to get access

Abstract

The aim was to evaluate the importance of the osmolarity of different oral agents for bowel distension and the level of related adverse events. The longitudinal design included the exposition of different oral MR agents on two separate occasions. Four groups of volunteers were randomly given 350 ml gastrografin of three different concentrations and water. On the second occasion they received mannitol, iohexol or iodixanol with equivalent osmolarities, but the control group (water) received mannitol. We recorded the outcomes as the degree of bowel distension determined as the mean bowel section area and the total level of discomfort recorded from a visual analogue scale (VAS). The statistical analysis included scatter plots with the best-fitted line with linear regression to study the association between osmolarity and section area and the association between osmolarity and adverse events. A dose-response association was found between increasing osmolarity levels and bowel area in square centimeters (P=0.00001). A similar dose-response association existed between increasing levels of osmolarity and adverse events (P=0.001). Osmolarity appears to be more important for bowel distension than the physico-chemical characteristics of the nonabsorbable oral agents. The optimum osmolarity level is determined by the patient’s tolerance of the adverse events.
Literature
1.
go back to reference Brown JJ (1996) Gastrointestinal contrast agents for MR imaging. Magn Reson Imaging Clin North Am 4:25–35 Brown JJ (1996) Gastrointestinal contrast agents for MR imaging. Magn Reson Imaging Clin North Am 4:25–35
3.
go back to reference Giovagnoni A, Fabbri A, Maccioni F (2002) Oral contrast agents in MRI of the gastrointestinal tract. Abdom Imaging 27:367–375CrossRefPubMed Giovagnoni A, Fabbri A, Maccioni F (2002) Oral contrast agents in MRI of the gastrointestinal tract. Abdom Imaging 27:367–375CrossRefPubMed
4.
go back to reference Schunk K (2002) Small bowel magnetic resonance imaging for imflammatory bowel disease. Top Magn Reson Imaging 13:409–425CrossRefPubMed Schunk K (2002) Small bowel magnetic resonance imaging for imflammatory bowel disease. Top Magn Reson Imaging 13:409–425CrossRefPubMed
5.
go back to reference Schwartz D (1981) Méthodes statistiques a l´usage des médecins et des biologistes. Troisieme édition. Flammarion médecine-sciences, Paris ISBN 2-257-10326-2 Schwartz D (1981) Méthodes statistiques a l´usage des médecins et des biologistes. Troisieme édition. Flammarion médecine-sciences, Paris ISBN 2-257-10326-2
6.
go back to reference Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H (2000) Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 215:717–725PubMed Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H (2000) Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 215:717–725PubMed
7.
go back to reference Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Maris T, Prassopoulos P (2000) MR imaging of the small bowel with a true FISP sequence after enteroclysis with water solution. Invest Radiol 35:707–711CrossRefPubMed Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Maris T, Prassopoulos P (2000) MR imaging of the small bowel with a true FISP sequence after enteroclysis with water solution. Invest Radiol 35:707–711CrossRefPubMed
8.
go back to reference Schreyer AG, Seitz J, Feuerbach S, Rogler G, Herfarth H (2004) Modern imaging using computer tomography and magnetic resonance imaging for inflammatory bowel disease (IBD) AU1. Inflamm Bowel Dis 10:45–54CrossRefPubMed Schreyer AG, Seitz J, Feuerbach S, Rogler G, Herfarth H (2004) Modern imaging using computer tomography and magnetic resonance imaging for inflammatory bowel disease (IBD) AU1. Inflamm Bowel Dis 10:45–54CrossRefPubMed
9.
go back to reference Lauenstein TC, Schneemann H, Vogt FM, Herborn CU, Rühm SG, Debatin JF (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228:279–283PubMedCrossRef Lauenstein TC, Schneemann H, Vogt FM, Herborn CU, Rühm SG, Debatin JF (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228:279–283PubMedCrossRef
10.
go back to reference Lomas DJ, Graves MJ (1999) Small bowel MRI using water as a contrast medium. Br J Radiol 72:994–997PubMed Lomas DJ, Graves MJ (1999) Small bowel MRI using water as a contrast medium. Br J Radiol 72:994–997PubMed
11.
go back to reference Laghi A, Carbone I, Catalano C, Iannaccone R, Paolantonio P, Baeli I, Trenna S, Passariello R (2001) Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR 177:1333–1334PubMed Laghi A, Carbone I, Catalano C, Iannaccone R, Paolantonio P, Baeli I, Trenna S, Passariello R (2001) Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR 177:1333–1334PubMed
12.
go back to reference Patak MA, Froehlich JM, von Weymarn C, Ritz MA, Zollikofer CL, Wentz KU (2001) Non-invasive distension of the small bowel for magnetic-resonance imaging. Lancet 358:987–988CrossRefPubMed Patak MA, Froehlich JM, von Weymarn C, Ritz MA, Zollikofer CL, Wentz KU (2001) Non-invasive distension of the small bowel for magnetic-resonance imaging. Lancet 358:987–988CrossRefPubMed
13.
go back to reference Born C, Nagel B, Leinsinger G, Reiser M (2003) MRI with oral filling in patients with chronic inflammatory bowel diseases. Radiologe 42:34–42CrossRef Born C, Nagel B, Leinsinger G, Reiser M (2003) MRI with oral filling in patients with chronic inflammatory bowel diseases. Radiologe 42:34–42CrossRef
14.
go back to reference Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC (2004) Dose optimization of mannitol solution for small bowel distension in MRI. J Magn Reson Imaging 20:648–653CrossRefPubMed Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC (2004) Dose optimization of mannitol solution for small bowel distension in MRI. J Magn Reson Imaging 20:648–653CrossRefPubMed
15.
go back to reference Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC (2004) Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol 14:458–464PubMedCrossRef Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC (2004) Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol 14:458–464PubMedCrossRef
16.
go back to reference Borthne AS, Abdelnoor M, Hellund JC, Geitung JT, Storaas T, Gjesdal KI, Kløw NE (2005) MR imaging of the small bowel with increasing concentrations of an oral osmotic agent. Eur Radiol 15:666–671PubMedCrossRef Borthne AS, Abdelnoor M, Hellund JC, Geitung JT, Storaas T, Gjesdal KI, Kløw NE (2005) MR imaging of the small bowel with increasing concentrations of an oral osmotic agent. Eur Radiol 15:666–671PubMedCrossRef
17.
go back to reference Ajaj W, Goyen M, Schneemann H, Kuehle C, Nuefer M, Ruehm S, Goehde S, Lauenstein T (2005) Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distension. Eur Radiol 15:1400–1406PubMedCrossRef Ajaj W, Goyen M, Schneemann H, Kuehle C, Nuefer M, Ruehm S, Goehde S, Lauenstein T (2005) Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distension. Eur Radiol 15:1400–1406PubMedCrossRef
18.
go back to reference Laerum F, Stordahl A, Solheim KE, Haugstvedt JR, Roald HE, Skinningsrud K (1991) Iodinated contrast agents and the gastrointestinal tract. Intestinal follow-through with iohexol and iopentol. Invest Radiol 26:177–181 Laerum F, Stordahl A, Solheim KE, Haugstvedt JR, Roald HE, Skinningsrud K (1991) Iodinated contrast agents and the gastrointestinal tract. Intestinal follow-through with iohexol and iopentol. Invest Radiol 26:177–181
19.
go back to reference Loennemark M, Magnusson A (1995) Oral contrast media in CT of the abdomen. Iohexol of different concentrations as a gastrointestinal contrast medium. Acta Radiol 36:396–398PubMedCrossRef Loennemark M, Magnusson A (1995) Oral contrast media in CT of the abdomen. Iohexol of different concentrations as a gastrointestinal contrast medium. Acta Radiol 36:396–398PubMedCrossRef
20.
go back to reference Borthne AS, Abdelnoor M, Rugtveit J, Perminow G, Reiseter T, Kløw NE (2005) Bowel magnetic resonance imaging of pediatric patients with oral mannitol. MRI compared to endoscopy and intestinal ultrasound. Eur Radiol DOI: 10.1007/s00330-005-2793-y Borthne AS, Abdelnoor M, Rugtveit J, Perminow G, Reiseter T, Kløw NE (2005) Bowel magnetic resonance imaging of pediatric patients with oral mannitol. MRI compared to endoscopy and intestinal ultrasound. Eur Radiol DOI: 10.1007/s00330-005-2793-y
21.
go back to reference Bigard M, Gaucher P, Lasalle C (1979) Fatal colonic explosion during colonoscopic polypectomy. Gastroenterology 77:1307–1310PubMed Bigard M, Gaucher P, Lasalle C (1979) Fatal colonic explosion during colonoscopic polypectomy. Gastroenterology 77:1307–1310PubMed
Metadata
Title
Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging
Authors
Arne S. Borthne
Michael Abdelnoor
Trygve Storaas
Claude Pierre-Jerome
Nils-E. Kløw
Publication date
01-06-2006
Publisher
Springer-Verlag
Published in
European Radiology / Issue 6/2006
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-005-0063-7

Other articles of this Issue 6/2006

European Radiology 6/2006 Go to the issue